The relation between hepatitis C virus and coronary heart disease

被引:9
|
作者
Metwally, Amr Hany [1 ]
Elgamal, Mohamed-Adel F. [1 ]
机构
[1] Mansoura Univ, Mansoura, Egypt
关键词
D O I
10.1016/j.mehy.2014.01.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It is well known that chronic hepatitis C is associated with insulin resistance and metabolic syndrome which are risk factors for atherosclerosis and coronary heart disease. As a result, chronic hepatitis C might be thought, through its association with metabolic syndrome, to increase the risk of myocardial infarction. However, unexpectedly it was found that HCV infection is not associated with an increased risk of myocardial infarction. We are providing here an hypothesis of the mechanism through which HCV infection does not increase the risk for myocardial infarction and also may be protecting against some cardiovascular risks that typically develop in many patients with metabolic syndrome who do not have chronic hepatitis C. The suggested mechanism includes factors that are normal consequences of chronic hepatitis, such as: significant decrease in cholesterol and LDL levels; defected blood clotting system; impaired myocardial function; decreased venous return and central venous pressure; increased nitric oxide and TNF alpha levels; and diminished cardiac beta receptors signal transduction. All these factors contribute to a protective effect against cardiac ischemia and coronary heart disease. We suggest further studies to investigate this hypothesis. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:505 / 505
页数:1
相关论文
共 50 条
  • [31] Hepatitis C virus and the disease that it produces
    Armas-Merino, R
    Wolff, C
    Soto, R
    Jirón, MI
    Parraguez, A
    REVISTA MEDICA DE CHILE, 1999, 127 (10) : 1240 - 1254
  • [32] Hepatitis C virus and kidney disease
    Martin, Paul
    Fabrizi, Fabrizio
    JOURNAL OF HEPATOLOGY, 2008, 49 (04) : 613 - 624
  • [33] Hepatitis C: virus, host, disease
    Ippolito, G
    Craxi, A
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (Suppl 1): : S1 - S2
  • [34] Hepatitis C: virus, host, disease
    G Ippolito
    A Craxi
    Cell Death & Differentiation, 2003, 10 : S1 - S2
  • [35] Hepatitis C virus and kidney disease
    Kamar, Nassim
    Alric, Laurent
    Izopet, Jacques
    Rostaing, Lionel
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (04) : 328 - 333
  • [36] Hepatitis C virus and rheumatic disease
    Wener, MH
    Johnson, RJ
    Sasso, EH
    Gretch, DR
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (06) : 953 - 959
  • [37] Hepatitis C virus: the burden of the disease
    Adler, M
    Goubau, P
    Nevens, F
    Van Vlierberghe, H
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02) : 83 - 86
  • [38] Hepatitis C Virus and Cardiovascular Disease
    Onoue, Kenji
    Saito, Yoshihiko
    CIRCULATION JOURNAL, 2018, 82 (06) : 1503 - 1504
  • [39] Can statins be used safely in coronary heart disease patients of Hepatitis B virus carriers?
    Zhang, Qing
    Yang, Zhijian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (02) : 291 - 291
  • [40] Hepatitis C virus infection and coronary artery disease: an updated meta-analysis
    De Vito, E.
    Gabrielli, E.
    Scudiero, F.
    Zocchi, C.
    Pallazola, V.
    Di Mario, C.
    Parodi, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 443 - 443